According to the new market research report "RNA Analysis/Transcriptomics Market by Product (Reagents, Instruments, Software), By Technology (Microarrays, NGS, Sanger), By Application (Clinical Diagnostics, Drug Discovery), By End User (CROs, Hospitals), COVID-19 Impact - Global Forecast to 2025", published by MarketsandMarkets™, the RNA analysis market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period.

Browse in-depth TOC on "RNA Analysis/Transcriptomics Market"
103 – Tables
38 – Figures
196 – Pages

Download PDF Brochure: marketsandmarkets.com/pdfdownloadNew.asp?id=2

The Growth in this market is primarily driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market. The increasing focus on biomarker discovery and toxicogenomics, along with the increasing interest in outsourcing services, is expected to offer significant growth opportunities for the players operating in the global market.

The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection. We estimate that the transcriptomic technologies adoption, along with personalized medicine, will grow at a stable pace in the next five years. Due to the increase in research activity, both the availability of funding for research and the demand for high-throughput technologies are expected to grow.